{"hands_on_practices": [{"introduction": "Metabolic pathways must be highly responsive to the fluctuating needs of the cell. Feedback inhibition is not merely a mechanism to prevent over-accumulation; it is a dynamic control system that also allows for the rapid acceleration of production when a product is in high demand. This exercise [@problem_id:2295317] explores this \"on-switch\" aspect of regulation, challenging you to predict the immediate consequences within a pathway when the final product is suddenly consumed, relieving the enzymatic \"brakes.\"", "problem": "In a microorganism, a linear biosynthetic pathway converts a precursor molecule, Substrate A, into a vital cellular component, Product D. The synthesis involves two intermediate compounds, B and C, following the sequence $A \\rightarrow B \\rightarrow C \\rightarrow D$. Each step is facilitated by a specific enzyme. The enzyme responsible for the first step of the pathway, converting A to B, is an allosteric enzyme. Its activity is inhibited when the final product, D, binds to a regulatory site on the enzyme. This mechanism allows the cell to regulate the production of D.\n\nImagine the microorganism is subjected to an environmental stress that requires it to rapidly utilize Product D for a separate defensive process. As a result, the intracellular pool of free Product D is quickly and significantly depleted. Assuming that the initial Substrate A is continuously supplied and is not a limiting factor, what will be the most immediate consequence for the intracellular concentrations of the pathway intermediates, B and C?\n\nA. The concentration of B will increase, and the concentration of C will increase.\n\nB. The concentration of B will decrease, and the concentration of C will decrease.\n\nC. The concentration of B will increase, and the concentration of C will decrease.\n\nD. The concentration of B will decrease, and the concentration of C will increase.\n\nE. The concentrations of both B and C will show no significant change.", "solution": "Let the pathway be $A \\xrightarrow{E_{1}} B \\xrightarrow{E_{2}} C \\xrightarrow{E_{3}} D$ with rates $v_{1}$, $v_{2}$, and $v_{3}$, respectively. The first enzyme $E_{1}$ is allosterically inhibited by the end product $D$. Represent this inhibition by writing $v_{1}=V_{1,\\max}\\,\\phi([D])$ with $\\frac{d\\phi}{d[D]}0$. Assume $A$ is continuously supplied and not limiting, so changes in $v_{1}$ are dominated by the change in $[D]$.\n\nBefore stress, in steady state, fluxes are equal:\n$$\nv_{1}^{0}=v_{2}^{0}=v_{3}^{0}=J_{0},\\quad [B]=[B]_{0},\\quad [C]=[C]_{0},\\quad [D]=[D]_{0}.\n$$\nEnvironmental stress rapidly depletes free $D$, so $[D]$ decreases to $[D]^{+} [D]_{0}$. Since $\\frac{d\\phi}{d[D]}0$, this immediately increases $v_{1}$:\n$$\nv_{1}^{+}=V_{1,\\max}\\,\\phi([D]^{+})>V_{1,\\max}\\,\\phi([D]_{0})=v_{1}^{0}.\n$$\nThe dynamics of intermediates are\n$$\n\\frac{d[B]}{dt}=v_{1}-v_{2}([B]),\\qquad \\frac{d[C]}{dt}=v_{2}([B]) - v_{3}([C]),\n$$\nwhere $v_{2}$ and $v_{3}$ are monotonically increasing functions of their substrates under standard enzyme kinetics.\n\nAt the instant after $[D]$ drops, $[B]$ and $[C]$ are still $[B]_{0}$ and $[C]_{0}$, so $v_{2}([B]_{0})=v_{3}([C]_{0})=J_{0}$, while $v_{1}$ has jumped to $v_{1}^{+}>J_{0}$. Therefore,\n$$\n\\left.\\frac{d[B]}{dt}\\right|_{t=0^{+}}=v_{1}^{+}-J_{0}>0,\\qquad \\left.\\frac{d[C]}{dt}\\right|_{t=0^{+}}=J_{0}-J_{0}=0.\n$$\nThus $[B]$ begins to increase immediately. As $[B]$ rises, $v_{2}([B])$ increases above $J_{0}$, which makes\n$$\n\\frac{d[C]}{dt}=v_{2}([B]) - v_{3}([C])>0\n$$\nuntil $[C]$ increases sufficiently for $v_{3}([C])$ to match the higher flux. Consequently, both $[B]$ and $[C]$ rise from their initial levels.\n\nAt the new steady state under continued low $[D]$, inhibition of $E_{1}$ remains relieved, so the pathway flux increases to some $J_{1}>J_{0}$ with $v_{1}=v_{2}=v_{3}=J_{1}$. For typical monotonic kinetics, achieving $v_{2}=J_{1}$ and $v_{3}=J_{1}$ with unchanged enzymes requires higher $[B]$ and $[C]$ than at $J_{0}$. Therefore, both intermediates increase.\n\nHence, the most immediate consequence is that the concentrations of both $B$ and $C$ increase.", "answer": "$$\\boxed{A}$$", "id": "2295317"}, {"introduction": "The principles of feedback inhibition become starkly clear when the system breaks. Genetic mutations can disable these elegant regulatory circuits, often with significant metabolic consequences. This practice problem [@problem_id:2046266] moves from qualitative prediction to quantitative analysis, asking you to calculate the specific impact of a mutation that renders an enzyme insensitive to its feedback inhibitor. By applying Michaelis-Menten kinetics to both a wild-type and a mutant scenario, you will quantify the metabolic imbalance that results from a loss of regulation.", "problem": "Consider a simplified linear metabolic pathway in a bacterial cell, which converts a substrate A into a final product D through two intermediate compounds, B and C:\n\n$A \\xrightarrow{E_1} B \\xrightarrow{E_2} C \\xrightarrow{E_3} D$\n\nThe first enzyme in the pathway, $E_1$, is an allosteric enzyme that is subject to non-competitive feedback inhibition by the final product, D. The other enzymes, $E_2$ and $E_3$, are not subject to regulation. All enzymes in the pathway follow Michaelis-Menten kinetics.\n\nThe system operates under the following conditions:\n1.  The concentration of the initial substrate, [A], is maintained at a constant, saturating level, such that it is much greater than the Michaelis constant of $E_1$ ($K_{M,1}$).\n2.  The pathway has reached a steady state, meaning the rates of production and consumption for each intermediate (B and C) are equal, and their concentrations are constant.\n3.  In a normal, wild-type cell, homeostatic mechanisms maintain the concentration of the final product D at a constant level equal to three times its inhibition constant for $E_1$ (i.e., $[D]_{\\text{wt}} = 3 K_I$, where $K_I$ is the inhibition constant).\n\nNow, consider a mutant strain of the bacterium. This strain possesses a mutation in the gene encoding for enzyme $E_1$. The resulting mutant enzyme, $E_{1,\\text{mut}}$, has the same catalytic properties ($V_{\\text{max},1}$ and $K_{M,1}$) as the wild-type enzyme, but its regulatory (allosteric) site is non-functional, completely preventing the binding of the inhibitor D.\n\nGiven the following kinetic parameters for the wild-type enzymes:\n-   Maximum velocity of $E_1$, $V_{\\text{max},1} = 0.50$ mM/s\n-   Maximum velocity of $E_2$, $V_{\\text{max},2} = 1.00$ mM/s\n-   Michaelis constant of $E_2$, $K_{M,2} = 1.50$ mM\n\nCalculate the ratio of the steady-state concentration of intermediate B in the mutant strain, $[B]_{\\text{mut}}$, to that in the wild-type strain, $[B]_{\\text{wt}}$. Express your answer as a single real number.", "solution": "Because all enzymes follow Michaelis-Menten kinetics and the pathway is at steady state, the production and consumption rates of intermediate B are equal:\n$$v_{1} = v_{2}.$$\n\nFor non-competitive inhibition of $E_{1}$ by $D$, the apparent maximum velocity is reduced while $K_{M,1}$ is unchanged. With $[A] \\gg K_{M,1}$, the rate of $E_{1}$ equals its apparent $V_{\\text{max}}$:\n$$v_{1,\\text{wt}} = \\frac{V_{\\text{max},1}}{1 + \\frac{[D]_{\\text{wt}}}{K_{I}}}.$$\nGiven $[D]_{\\text{wt}} = 3 K_{I}$, we obtain\n$$v_{1,\\text{wt}} = \\frac{V_{\\text{max},1}}{1 + 3} = \\frac{V_{\\text{max},1}}{4}.$$\nIn the mutant, the inhibitor cannot bind, so with $[A]$ saturating,\n$$v_{1,\\text{mut}} = V_{\\text{max},1}.$$\n\nThe $E_{2}$ step follows Michaelis-Menten kinetics with substrate $B$:\n$$v_{2} = \\frac{V_{\\text{max},2}\\,[B]}{K_{M,2} + [B]}.$$\nAt steady state for each strain,\n$$v_{1} = v_{2} \\implies v \\left(K_{M,2} + [B]\\right) = V_{\\text{max},2}\\,[B],$$\nwhich rearranges to\n$$v\\,K_{M,2} = \\left(V_{\\text{max},2} - v\\right)[B] \\implies [B] = \\frac{v\\,K_{M,2}}{V_{\\text{max},2} - v}.$$\n\nApplying this to wild-type and mutant:\n$$[B]_{\\text{wt}} = \\frac{\\left(\\frac{V_{\\text{max},1}}{4}\\right) K_{M,2}}{V_{\\text{max},2} - \\frac{V_{\\text{max},1}}{4}}, \\quad [B]_{\\text{mut}} = \\frac{V_{\\text{max},1}\\,K_{M,2}}{V_{\\text{max},2} - V_{\\text{max},1}}.$$\n\nTheir ratio simplifies to\n$$\\frac{[B]_{\\text{mut}}}{[B]_{\\text{wt}}} = \\frac{\\dfrac{V_{\\text{max},1}\\,K_{M,2}}{V_{\\text{max},2} - V_{\\text{max},1}}}{\\dfrac{\\left(\\frac{V_{\\text{max},1}}{4}\\right) K_{M,2}}{V_{\\text{max},2} - \\frac{V_{\\text{max},1}}{4}}} = \\frac{V_{\\text{max},1}}{V_{\\text{max},2} - V_{\\text{max},1}} \\cdot \\frac{V_{\\text{max},2} - \\frac{V_{\\text{max},1}}{4}}{\\frac{V_{\\text{max},1}}{4}} = 4\\,\\frac{V_{\\text{max},2} - \\frac{V_{\\text{max},1}}{4}}{V_{\\text{max},2} - V_{\\text{max},1}}.$$\n\nSubstituting the given values $V_{\\text{max},1} = 0.50$ and $V_{\\text{max},2} = 1.00$ (units cancel in the ratio),\n$$\\frac{[B]_{\\text{mut}}}{[B]_{\\text{wt}}} = 4 \\cdot \\frac{1.00 - \\frac{0.50}{4}}{1.00 - 0.50} = 4 \\cdot \\frac{1.00 - 0.125}{0.50} = 4 \\cdot \\frac{0.875}{0.50} = 4 \\cdot 1.75 = 7.$$\nTherefore, the mutant has a sevenfold higher steady-state concentration of intermediate B compared to the wild type.", "answer": "$$\\boxed{7}$$", "id": "2046266"}, {"introduction": "Cellular metabolism is more of a complex road network than a simple one-way street, with many pathways branching to create different products from a common precursor. This creates a significant regulatory challenge: how can the cell independently manage the production of one product without affecting the other? This problem [@problem_id:2295343] puts you in the role of a metabolic engineer, tasking you with designing the most logical and efficient feedback scheme for a branched pathway. Evaluating the options will solidify your understanding of how nature strategically places its control points to maintain homeostasis.", "problem": "A bioengineering firm is modifying a bacterial strain to produce two distinct, commercially valuable secondary metabolites, Compound X and Compound Y. The synthesis of these compounds originates from a common cellular precursor, Metabolite A. The simplified metabolic pathway is as follows:\n\n1.  Metabolite A is converted to Intermediate B by Enzyme E1.\n2.  Intermediate B is the branch point.\n3.  The pathway to Compound X proceeds from Intermediate B, which is converted to Intermediate C by Enzyme E2, and then Intermediate C is converted to the final product Compound X by Enzyme E3.\n4.  The pathway to Compound Y proceeds from Intermediate B, which is converted to Intermediate D by Enzyme E4, and then Intermediate D is converted to the final product Compound Y by Enzyme E5.\n\nThe firm needs to implement a negative feedback regulation system to ensure that the production of each compound can be independently controlled. For instance, if the cell has accumulated a sufficient amount of Compound X, its synthesis should be selectively shut down without affecting the synthesis of Compound Y, and vice versa. Several potential regulatory schemes have been proposed. Which of the following feedback inhibition schemes would be the most effective and metabolically efficient for achieving this independent regulation?\n\nA. Compound X allosterically inhibits Enzyme E2, and Compound Y allosterically inhibits Enzyme E4.\n\nB. Both Compound X and Compound Y allosterically inhibit Enzyme E1.\n\nC. Compound X allosterically inhibits Enzyme E4, and Compound Y allosterically inhibits Enzyme E2.\n\nD. Compound X allosterically inhibits Enzyme E3, and Compound Y allosterically inhibits Enzyme E5.\n\nE. Metabolite A allosterically inhibits both Enzyme E3 and Enzyme E5.", "solution": "Goal: implement negative feedback allowing independent control of the two branches that diverge at the common branch point. The correct design principle is end-product inhibition of the first committed, branch-specific step so that (i) accumulation of a given product selectively shuts its own branch without affecting the other branch, and (ii) flux is halted as early as possible to avoid wasteful accumulation of intermediates and unnecessary consumption of precursors and energy.\n\nIdentify the branch-specific first committed steps:\n- For production of $X$, the first reaction unique to this branch is $B \\xrightarrow{E_{2}} C$. Therefore, $X$ should inhibit $E_{2}$.\n- For production of $Y$, the first reaction unique to this branch is $B \\xrightarrow{E_{4}} D$. Therefore, $Y$ should inhibit $E_{4}$.\n\nEvaluate each option against these criteria:\n- Option A: $X$ allosterically inhibits $E_{2}$ and $Y$ allosterically inhibits $E_{4}$. This implements end-product inhibition at the first committed step in each branch. It provides independent control: accumulation of $X$ reduces only the $B \\to C$ flux, leaving $B \\to D$ unaffected; accumulation of $Y$ reduces only the $B \\to D$ flux, leaving $B \\to C$ unaffected. It is also metabolically efficient because it halts flux at the earliest branch-unique step, minimizing buildup of intermediates and unnecessary use of $A$.\n- Option B: Both $X$ and $Y$ inhibit $E_{1}$. Because $E_{1}$ is upstream of the branch point and common to both products, accumulation of either $X$ or $Y$ would suppress flux to both branches, violating the requirement for independent regulation and reducing metabolic efficiency when only one product is in excess.\n- Option C: $X$ inhibits $E_{4}$ and $Y$ inhibits $E_{2}$. This cross-inhibition creates negative coupling between branches: accumulation of $X$ throttles the $Y$ branch and vice versa. It does not provide independent regulation and is counter to the design goal.\n- Option D: $X$ inhibits $E_{3}$ and $Y$ inhibits $E_{5}$. Inhibiting the terminal enzymes allows continued flux through $E_{2}$ and $E_{4}$, causing accumulation of intermediates $C$ and $D$ and wasted consumption of $A$ and cofactors. This is less metabolically efficient and does not stop the branch at its first committed step.\n- Option E: $A$ inhibits $E_{3}$ and $E_{5}$. This is not end-product feedback and is not responsive to levels of $X$ or $Y$. It fails to achieve selective shutdown when $X$ or $Y$ accumulates, and it also targets terminal steps with the same inefficiency noted above.\n\nTherefore, the most effective and metabolically efficient scheme for independent regulation is end-product inhibition at the first committed step of each branch, as in Option A.", "answer": "$$\\boxed{A}$$", "id": "2295343"}]}